Mikolasevic I MS,Wensveen TT,Grgic I,Jakopcic I,Stimac D .2016 .Nonalcoholic fatty liver disease - A multisystem disease. World Journal Gastroenterology, 22(43) : 9488-9505.
Darvishi M AK,Toama MA,Hadrawi SK,Ramadan MF,Pirhadi M .2023 .A Review of the Effects of Omega-3 and Omega-6 on Alcoholic and Non-Alcoholic Fatty Liver. , 10(4) : 530-536.
Çiftçioğlu M KB,Ispiroğlu M .2023 .Gişi K. Frequency of fibrosis in patients with incidentally detected hepatosteatosis. Revista da Associação Médica Brasileira, 70(1) : 1-5.
Waseem M SF,Khan R .2022 .Ultrasound Detected Non-Alcoholic Fatty Liver Disease Prevalence and its Risk Factors in Pakistani Population. , 9(4) : 607-611.
Joseph AE SS,al-Sam S,Cook MG,Maxwell JD .1991 .Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clinical radiology, 43(1) : 26-31.
Dasarathy S DJ,Khiyami A,Joseph R,Lopez R,McCullough AJ .2009 .Validity of real-time ultrasound in the diagnosis of hepatic steatosis: a prospective study. Journal of hepatology, 51(6) : 1061-1067.
Shiralkar K JS,Bluth EI,Marshall RH,Dornelles A,Gulotta PM .2015 .Improved method for calculating hepatic steatosis using the hepatorenal index. Journal of Ultrasound in Medicine, 34(6) : 1051-1059.
Ballestri S LA,Romagnoli D,Carulli L,Losi L,Day CP .2012 .Ultrasonographic fatty liver indicator, a novel score that rules out NASH and is correlated with metabolic parameters in NAFLD. , 32(8) : 1242-1252.
Chan WK NMN,Mahadeva S. .2014 .Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. Journal of gastroenterology and hepatology, 29(7) : 1470-1476.
Sasso M BM,de Ledinghen V,Douvin C,Marcellin P,Poupon R .2010 .Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound in medicine & biology, 36(11) : 1825-1835.
Lau Liu K WV,Liu K,Tse SD,Yip YK,TC YK .2017 .Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. Official journal of the American College of Gastroenterology| ACG, 112(12) : 1812-1823.
De Matteis C CM ,Graziano G,Battaglia S,Suppressa P,Piazzolla G .2021 .AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. Scientific Reports, 11(1) : 1-14.
. .Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.. , : .
.2018 .. Journal of gastroenterology and hepatology, 33(1) : 270-276.
.2010 .. Journal of hepatology, 52(4) : 579-585.
.2022 .. Annals of Hepatology, 27(2) : 1-6.
Tovo C V. V-NC ,Leite NC,Panke CL,Port GZ,Fernandes S .2019 .Transient hepatic elastography has the best performance in evaluating liver fibrosis in non-alcoholic fatty liver disease (NAFLD). Annals of hepatology, 18(3) : 445-449.
Vuppalanchi R ÜA ML,Cummings OW,Sandrasegaran KE,Hameed T .2009 .. Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 7(4) : 481-486.
.2023 .Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis. Annals of Hepatology, 28(1) : 1-10.
Lavine Chalasani N YZ,Charlton JE,Cusi M,Rinella K,M K .2018 .The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. , 67(1) : 328-357.
.2020 .Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , : .
Hepatology Research .2021 .. , 51(10) : 1013-1025.
HY. K. .2021 .Recent advances in nonalcoholic fatty liver disease metabolomics. Clinical and molecular hepatology, 27(4) : 553-559.
Krznaric-Zrnic Mikolasevic I DV,Krznaric I,Virovic-Jukic Z,Stojsavljevic L,Grgurevic S,Milic I,Vukoja S,Puz I,Aralica P,Hauser M,G. M .2022 .The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy. , 58(2) : 1-14.
Kim Chung J PH,Yu YJ,Park MH,Jung S,SI S .2021 .Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population. Diagnostics (Basel), 11(12) : .
.2022 .Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. , 12(2) : 1-11.
. .To read a copy of this license please visit: https://creativecommons. , : .